CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
R.grid
United Kingdom
- London
- 06/11/2024
- Unknown
- $6,500,000
Research Grid (R.grid) is an automation engine for admin-free clinical trials. Our mission is to enable faster, more successful clinical trials by engineering smart software that safely automates back-office admin across the full trial life cycle. Informed by deep expertise and first-hand experience, we have built comprehensive solutions for patient and community engagement (Inclusive) and clinical trial management (TrialEngine) that support a variety of trial types and therapeutic areas.
More about TrialEngine: https://www.trialengine.ai/
More about Inclusive: https://inclusive.health/
- Industry Research
- Website https://rgrid.tech/
- LinkedIn https://www.linkedin.com/company/rgrid/
Related People
Amber Michelle H.Founder
United Kingdom -
London, England
My academic background is in translational and biomedical neuroscience, whereas my entrepreneurial background is focused on creative and intelligent digital strategies in healthcare to improve outcomes.
I have a strong interest in practical and unconventional applications of neuroscience, R&D, and machine learning to address global challenges in medical research. I'm particularly interested in making clinical operations and patient inclusion more efficient, effective, diverse, and embedded.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)